Abiopharma

New Form 8-K - Salarius Pharmaceuticals, Inc. Filed: 2025-08-18 AccNo: 0001615219-25-000107 Size: 147 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 8-K - PALATIN TECHNOLOGIES INC Filed: 2025-08-18 AccNo: 0001654954-25-009743 Size: 179 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - MYRIAD GENETICS INC Filed: 2025-08-18 AccNo: 0000899923-25-000089 Size: 238 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Journey Medical Corporation to Present at the Emerging Growth Conference

New Form 6-K - Biodexa Pharmaceuticals Plc Filed: 2025-08-18 AccNo: 0001171843-25-005464 Size: 21 KB

New Form 8-K - Ultragenyx Pharmaceutical Inc. Filed: 2025-08-18 AccNo: 0000950170-25-109570 Size: 154 KB Item 8.01: Other Events

Journey Medical Corporation to Present at the Emerging Growth Conference

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Myriad Genetics Appoints Ben Wheeler Chief Financial Officer

Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy

Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)

Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR

New Form 424B5 - ECOLAB INC. Filed: 2025-08-18 AccNo: 0001104659-25-079518 Size: 511 KB

New Form SC TO-T - HilleVax, Inc. Filed: 2025-08-18 AccNo: 0001193125-25-182241 Size: 869 KB

Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles